Is EIDX A Good Stock To Buy Now?
While the market driven by short-term sentiment influenced by the accomodative interest rate environment in the US, virus news and stimulus talks, many smart money investors are starting to get cautious...
Eidos Therapeutics Inc. (EIDX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Marshall Wace LLP Paul Marshall And Ian Wace | 0 | $0 | 0% | |
| 2. | Perceptive Advisors Joseph Edelman | 0 | $0 | 0% | |
| 3. | Alpine Associates Robert Emil Zoellner | 0 | $0 | 0% | |
| 4. | GAMCO Investors Mario Gabelli | 0 | $0 | 0% | |
| 5. | Magnetar Capital Alec Litowitz And Ross Laser | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.00 | 14,428,836 | Large Shareholder | 1,000 | 2021-01-26 | Filing | |
| $29.90 | 882,353 | Large Shareholder, Officer, Director | 24,575,501 | 2019-07-03 | Filing | |
| $29.90 | 882,353 | Large Shareholder, Director | 24,575,501 | 2019-07-03 | Filing | |
| $29.90 | 882,353 | Large Shareholder, Director | 24,575,501 | 2019-07-03 | Filing | |
| $29.90 | 882,353 | Large Shareholder | 24,575,501 | 2019-07-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $126.39 | 300 | Officer, Director | 306,525 | 2021-01-13 | Filing | |
| $125.35 | 2,000 | Officer, Director | 306,825 | 2021-01-13 | Filing | |
| $124.72 | 4,934 | Officer, Director | 308,825 | 2021-01-13 | Filing | |
| $123.48 | 1,498 | Officer, Director | 313,759 | 2021-01-13 | Filing | |
| $122.27 | 572 | Officer, Director | 315,257 | 2021-01-13 | Filing |
Institutional Investors' Holdings
News See All
Hedge Funds Are Dumping Eidos Therapeutics, Inc. (EIDX)
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Hedge Funds Have Never Been This Bullish On Eidos Therapeutics, Inc. (EIDX)
Coronavirus is probably the #1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW.
Eidos Therapeutics, Inc. (EIDX): Are Hedge Funds Right About This Stock?
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November.
Hedge Funds Are Buying Eidos Therapeutics, Inc. (EIDX)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Did Hedge Funds Drop The Ball On Eidos Therapeutics, Inc. (EIDX) ?
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips on the charts, usually don't make them change their opinion towards a company...
Hedge Fund and Insider Trading News: Ray Dalio, Edward Lampert, Cyrus Capital, Chesapeake Energy Co. (CHK), Scientific Games Corp (SGMS), Rimini Street Inc (RMNI), and More
A bankruptcy judge approved Sears Holdings Corp.’s sale of notes to Cyrus Capital Partners even as he called the outcome “odd,” ending a chapter in the hedge fund’s efforts to keep its payouts...
Is Eidos Therapeutics, Inc. (EIDX) A Good Stock To Buy?
We at Insider Monkey have gone over 700 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of September...
Hedge Fund and Insider Trading News: Clint Carlson, Bandera Partners, TheStreet, Inc. (TST), Eidos Therapeutics Inc (EIDX), Arcimoto Inc (FUV), and More
Clint Carlson's Dallas-based hedge fund is losing another senior member of its team.
Hedge Fund and Insider Trading News: Bill Miller, David Stemerman, Eidos Therapeutics Inc (EIDX), Jerrick Media Holdings Inc (JMDA), Xencor Inc (XNCR), and More
Legendary value investor Bill Miller says value plays are not just cheap stocks. He looks for companies focused on high returns on invested capital and free-cash-flow growth.